🟢 Korro Bio is trading 10.4% up with no confirmed direct catalyst

Korro Bio is trading up 10.44% at $15.81 on November 2, 2026, with no confirmed direct catalyst.

• No clear company-specific announcement or filing dated November 2, 2026, was identified.
• The latest major company news was October 22 preclinical data for KRRO-111, including strong RNA-editing results and a planned regulatory submission in the first half of 2027. This news predates the session, and available evidence does not establish it as the cause of the move.